Quest Diagnostics Incorporated , the nation's leading provider of diagnostic testing, information and services, announced that Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to speak at the Salomon Smith Barney 2002 Global Health Care Conference on Monday, October 28, 2002, at The Plaza Hotel in New York City. The Quest Diagnostics presentation is scheduled to begin at 10:15 a.m. Eastern Time.
The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://www.veracast.com/ssb/2002/healthcare/57105198.cfm and to the public on http://www.questdiagnostics.com/ . In addition, the archived webcast will be available until Wednesday, November 27, 2002.
Quest Diagnostics Incorporated is the nation's leading provider of diagnostic testing, information and services, providing insights that enable physicians, hospitals, managed care organizations and other healthcare professionals to make decisions to improve health. The company offers the broadest access to diagnostic laboratory services through its national network of laboratories and patient service centers. Quest Diagnostics is the leading provider of esoteric testing, including gene-based medical testing, and empowers healthcare organizations and clinicians with state-of-the-art connectivity solutions that improve practice management. Additional company information can be found on the Internet at: http://www.questdiagnostics.com/ .
The statements in this press release which are not historical facts or information may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results and outcomes to be materially different. Certain of these risks and uncertainties may include, but are not limited to, unanticipated expenditures, changing relationships with customers, suppliers and strategic partners, conditions of the economy and other factors described in the Quest Diagnostics Incorporated 2001 Form 10-K and subsequent filings.
SOURCE: Quest Diagnostics Incorporated
CONTACT: Gary Samuels, Media, +1-201-393-5700, or Laure Park, Investors,
+1-201-393-5030, both of Quest Diagnostics Incorporated
Web site: http://www.questdiagnostics.com/